首页> 外文OA文献 >Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors

【2h】

Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC），以早期预测Her2 / neu阳性肿瘤患者的预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gajda, M.; Camara, O.; Oppel, S.; Kroll, T.; Jörke, C.; Krauspe, S.; Hammer, U.; Rabenstein, C.; Untch, M.; Runnebaum, I. B.; Pachmann, K.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. 基于上皮-间质转化标志物的循环肿瘤细胞表型检测对HER2阴性转移性乳腺癌一线化疗的预后意义 [J] . Xiuwen Guan, Ruigang Cai, Ying Fan, 癌症（英文版） . 2019,第009期
2. Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2eu-positive tumors [J] . M. Gajda1 O. Camara2 S. Oppel3 T. Kroll3 C. J?rke3 S. Krauspe2 U. Hammer3 C. Rabenstein4 M. Untch5 I. B. Runnebaum2 and K. Pachmann3 Annals of Oncology . 2008,第12期

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC），以早期预测Her2 / neu阳性肿瘤患者的预后
3. The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. [J] . Camara O, Rengsberger M, Egbe A, Annals of oncology: official journal of the European Society for Medical Oncology . 2007,第9期

机译：循环上皮肿瘤细胞（CETC）与乳腺癌新辅助（原发性全身）化疗期间治疗监测的相关性。
4. The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer [J] . O Camara1 M Rengsberger2 A Egbe1 A Koch2 M Gajda3 U Hammer2 C J?rke2 C Rabenstein4 M Untch5 and K Pachmann24 Annals of Oncology . 2007,第9期

机译：乳腺癌新辅助（原发性）化疗期间循环上皮肿瘤细胞（CETC）与治疗监测的相关性
5. OUTCOME FOLLOWING ADJUVANT VINBLASTINE, PREDNISONE AND LOMUSTINE CHEMOTHERAPY FOR HIGH-RISK CANINE MAST CELL TUMORS (MCTS) [C] . Kristen Weishaar, Craig Clifford, Tammy Murphy, Annual Conference of the Veterinary Cancer Society . 2009

机译：辅助温蜂蝶，泼尼松和Lomustine化疗后的结果，高危犬肥大细胞肿瘤（MCTS）
6. Detection of circulating tumor cells in the peripheral blood of solid tumor patients. [D] . Ladanyi, Andras. 2007

机译：实体瘤患者外周血中循环肿瘤细胞的检测。
7. Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2eu-positive tumors [O] . M. Gajda, O. Camara, S. Oppel, -1

机译：在主要系统化疗期间（包括曲妥珠单抗）监测循环上皮肿瘤细胞（CETC）以早期预测Her2 / neu阳性肿瘤患者的预后
8. Efficacy control of therapy using circulating epithelial tumor cells (CETC) as “Liquid Biopsy”: trastuzumab in HER2/neu-positive breast carcinoma [O] . Katharina Pachmann, O. Camara, T. Kroll, 2011

机译：使用循环上皮肿瘤细胞（CETC）作为“液体活检”的疗效控制：曲妥珠单抗治疗HER2 / neu阳性乳腺癌

Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors

著录项

引文网络

相似文献

相关主题

期刊订阅